Eden Maack

Associate Editor @i3health and Oncology Data Advisor ( Follow for #oncology updates and expert exclusives in #CancerResearch and treatment!

[Oncology Data Advisor @OncData]

What do you think about this week's #FDA approval of #irinotecan liposome/oxaliplatin/fluorouracil/leucovorin (#NALIRIFOX) for first-line treatment of metastatic #pancreatic adenocarcinoma?

Share your opinions in the comments!
@onctom #pancsm

Read more: https://t.co/AD01onkOtL

[OncData Lyn @OncDataLyn]

Don't miss this interview recorded #LIVE at #ONSCongress in which Elizabeth Archer-Nanda and Meagan Dwyer discuss their presentation regarding creating a more compassionate and #trauma-informed approach to #cancer patient's #MentalHealth
#oncology
https://t.co/ry9uVTPunm

[KeiraSmith_OncData @Keira_OncData]

Watching @Elizabe93802736 of @i3health @OncData present medical education research at @oncologynursing Congress!

#ONSCongress #ONS23

Abstracts coauthored by @Lyn_i3Health @Eden_i3Health @SI3health and @ConveyMed!

[Eden Maack @Eden_i3Health]

Expiring soon!

Enjoy this informative interview and accredited podcast activity on advances in #NSCLC clinical trials with @LealTiciana, Director of Thoracic Medical Oncology at Winship Cancer Institute
https://t.co/m8CAj7hEk8

[i3 Health @i3health]

🚨 Expiring soon! Listen to this #accredited #cme #ncpd #podcast episode on #Immunotherapy-based strategies for non–small cell #LungCancer now before it's too late!

Earn 1.25 CME/NCPD credit for FREE!

#oncology #pulmonology #MedEd #OncTwitter #MedTwitter

[i3 Health @i3health]

We are excited to announce Constance Visovsky (@connievisovsky1), PhD, RN, Director of the @USFHealthNurse, as Chairperson for ODACon 2022 - Supportive Care Summit: Managing Toxicities of Novel Breast Cancer Therapies.

Register here with code FALL22: https://t.co/W3FZRzBLIe

[ANCC NCPD Accreditation Program @ANCCcne]

Congratulations to all 💜🌟 https://t.co/3mFGSloRYb

[KeiraSmith_OncData @Keira_OncData]

Watch this exciting faculty preview of #ODACon Supportive Care Summit: Managing #Toxicities of Novel #Breast Cancer Therapies with our 4 expert nurse faculty, @connievisovsky1, @AbbeyKaler, Julia LaBarbera, and Janie Metsker!

https://t.co/NPR69wXAE9

#BreastCancerAwarenessMonth

[Eden Maack @Eden_i3Health]

@i3health is honored to be a 2022 recipient of the @ANCCOfficial #NCPD Premier Award!

https://t.co/UeEUddAw9W

#NursingEducation #ANCC #ANCCNCPDSummit #OnlineNursing

[Eden Maack @Eden_i3Health]

Come explore #OncData's new Data Hubs! Data hubs provide relevant content, news, and interviews categorized by tumor type to make it easy to find up-to-date information from across the cancer care landscape! Check it out here: https://t.co/cDgdph6TEh

[KeiraSmith_OncData @Keira_OncData]

Check out this #BloodCancerAwarenessMonth podcast with @majorajay and @RahulBanerjeeMD about exploring the use of #patient-reported outcomes (#PROs) in #blood cancers!
https://t.co/s8iJbOCnyZ
#OncData #lymsm #mmsm #hematology

[OncData Lyn @OncDataLyn]

Presenting #ODACon™ 2022 Support Care Summit! This virtual conference will engage attendees through 7 case-based discussions to apply emerging data and strategies for managing and supporting patients with #BreastCancer. Register now! https://t.co/5XIFzWm4WY
DM me for a discount!

[Eden Maack @Eden_i3Health]

At #ASCO22, Jessica Jones, MD, of @UTHealthHouston spoke with us about disparities in #breastcancer mortality and morbidity in women of color and strategies to reduce these disparities through early detection. Listen to the interview with #oncdata for more https://t.co/3CSjmhHkMa

[Eden Maack @Eden_i3Health]

In this interview with #OncData, Dr. Jochen Lorch @DrJLorch of @LurieCancer discusses timing of treatment, treatment sequencing, and targeted therapy for advanced #thyroidcancer. Read more here!
https://t.co/9Bc9pZrsRr

[OncData Lyn @OncDataLyn]

You're invited! @i3health is hosting a live #CME/#NCPD-approved webinar, Diagnosis and Evidence-Based Management of T-Cell #Lymphoma, presented by Aaron Goodman (@AaronGoodman33)! For more information and to sign-up for this special event: https://t.co/LZ2lnOkOP3

[Eden Maack @Eden_i3Health]

The #FDA has approved #nivolumab as neoadjuvant therapy for resectable non-small cell #lungcancer, based on the results of the #CheckMate-816 lead by @FordePatrick of @HopkinsThoracic and @DoctorJSpicer of @McgillOncology. Read more now! https://t.co/5fWRIevblN

[Eden Maack @Eden_i3Health]

The #FDA has approved #pacritinib for intermediate- to high-risk #myelofibrosis with severe thrombocytopenia, based on the results of #PERSIST-2 lead by John Mascarenhas, MD, of @IcahnMountSinai and @JeannePalmerMD of @MayoClinic. Read more now! https://t.co/Jk9Xe3I0KY

[Eden Maack @Eden_i3Health]

The #FDA has approved #pembrolizumab as adjuvant treatment for adult and pediatric patients ≥12 years old with fully resected stage IIB or IIC #melanoma, based on results of #KEYNOTE716 led by @JasonLukeMD of @UPMCHillmanCC. Read more now! https://t.co/6mrdliYi48